Kuntarahoitus Oyj:n ennenaikaisesti eräännyttämä joukkovelkakirja on poistettu pörssilistalta
June 25, 2024 03:00 ET
|
Kuntarahoitus Oyj
Kuntarahoitus OyjPörssitiedote25.6.2024 klo 10.00 Kuntarahoitus Oyj:n ennenaikaisesti eräännyttämä joukkovelkakirja on poistettu pörssilistalta Kuntarahoitus Oyj ilmoitti 11.6.2024...
The notes redeemed by Municipality Finance have been removed from trading at Nasdaq Helsinki
June 25, 2024 03:00 ET
|
Municipality Finance Plc
Municipality Finance PlcStock exchange release 25 June 2024 at 10:00 am (EEST) The notes redeemed by Municipality Finance have been removed from trading at Nasdaq Helsinki On 11 June 2024...
Roche’s OCREVUS subcutaneous administration approved by European Commission, as first and only twice-a-year injection for relapsing and primary progressive multiple sclerosis
June 25, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
OCREVUS subcutaneous (SC) injection offers a new, 10-minute administration of OCREVUS with comparable efficacy and safety to intravenous infusion (IV) OCREVUS SC provides an additional treatment...
Tecan ernennt Mukta Acharya zur Leiterin der Division Life Sciences Business
June 24, 2024 14:00 ET
|
Tecan Group AG
Tecan ernennt Mukta Acharya zur Leiterin der Division Life Sciences Business Männedorf, Schweiz, 24. Juni 2024 - Die Tecan Group (SIX Swiss Exchange: TECN) gab heute bekannt, dass Mukta...
Tecan appoints Mukta Acharya Head of the Life Sciences Business division
June 24, 2024 14:00 ET
|
Tecan Group AG
Tecan appoints Mukta Acharya Head of the Life Sciences Business division Männedorf, Switzerland, June 24, 2024 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Mukta Acharya,...
Roche launches new analytical units for cobas® pro integrated solutions delivering greater efficiency and capacity to laboratories
June 24, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
The cobas® c 703 and cobas® ISE neo analytical units, deliver higher testing capacity and increased automation helping to improve laboratory workflows and advance patient care.The new cobas c 703...
"Anleger sollten mindestens 3% digitale Vermögenswerte in ihren Portfolios haben"
June 21, 2024 10:30 ET
|
issuance.swiss AG
Zürich, 21. Juni 2024 - Auf dem ersten ETP Summit, der eine Bestandsaufnahme der Trends in der Branche der digitalen Vermögenswerte vornahm, betonte die Gemeinschaft der Finanzexperten, wie wichtig es...
« Les investisseurs doivent avoir au moins 3% d’actifs numériques dans leur portefeuille »
June 21, 2024 10:30 ET
|
issuance.swiss AG
Zurich, le 21 juin 2024 – Réunie pour faire un état des lieux des tendances de l’industrie des actifs numériques dans le cadre du premier ETP Summit, la communauté des experts financiers a souligné...
ETP Summit Financial Experts Advocate up to 3% Digital Asset Allocation in "Portfolio 3.0"
June 21, 2024 10:30 ET
|
issuance.swiss AG
ZURICH, June 21, 2024 - At the inaugural ETP Summit in Zurich last week, leading financial experts called for a paradigm shift in portfolio management, recommending a 3-5% allocation to digital assets...
Idorsia’s novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the ‘Primary & Speciality’ category
June 21, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Idorsia’s dual orexin receptor antagonist, a drug working by a new mechanism of action for the treatment of chronic insomnia, has been awarded the prestigious Prix Galien Suisse 2024 innovation prize...